SRPT vs WSBCO
Sarepta Therapeutics Inc (SRPT) versus WesBanco, Inc. (WSBCO) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
WesBanco, Inc. (WSBCO) is a banks - regional company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
WSBCO does not have a complete income-statement cache yet.
SRPT currently screens at market cap $2.34B. WSBCO currently screens at market cap $0.
Not investment advice. Open the SRPT and WSBCO stock pages for the full models.
Not investment advice.